Multi-center Controlled Clinical Trials in Alport Syndrome-A Feasibility Study
Sponsor: Hôpital Necker-Enfants Malades
Listed as NCT01696253, this observational or N/A phase trial focuses on Alport Syndrome and remains completed. Sponsored by Hôpital Necker-Enfants Malades, it has been updated 12 times since 2012, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Dec 2021 [monthly]
Completed
-
Nov 2020 — Jan 2021 [monthly]
Completed
▶ Show 7 earlier versions
-
Nov 2019 — Nov 2020 [monthly]
Completed
-
Jun 2018 — Nov 2019 [monthly]
Completed
-
May 2018 — Jun 2018 [monthly]
Completed
-
Apr 2018 — May 2018 [monthly]
Completed
Status: Active Not Recruiting → Completed · Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Active Not Recruiting NA
-
May 2017 — Aug 2017 [monthly]
Active Not Recruiting NA
-
Jan 2017 — May 2017 [monthly]
Active Not Recruiting NA
First recorded
Sep 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Hôpital Necker-Enfants Malades
- Peking University First Hospital
- University of Göttingen
- University of Minnesota
- University of Toronto
- University of Utah
For direct contact, visit the study record on ClinicalTrials.gov .